Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q3 2025 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2025-10-17

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Oct 17, 2025

Total Value: $744M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 65.0%

Value $484M Shares 19,963,157 Share Price $24.25 Est. Cost/Share $20.88 Unrealized @ Report Date —

PHAT PHATHOM PHARMACEUTICALS INC 11.8%

Value $87.86M Shares 7,464,572 Share Price $11.77 Est. Cost/Share $13.72 Unrealized @ Report Date -14.2%

NAMS NEWAMSTERDAM PHARMA COMPANY 11.0%

Value $81.61M Shares 2,869,565 Share Price $28.44 Est. Cost/Share $10.96 Unrealized @ Report Date +159.6%

— RAPT THERAPEUTICS INC 9.7%

Value $72.06M Shares 2,794,000 Share Price $25.79 Est. Cost/Share $25.79 Unrealized @ Report Date —

AURA AURA BIOSCIENCES INC 2.5%

Value $18.79M Shares 3,039,892 Share Price $6.18 Est. Cost/Share $17.87 Unrealized @ Report Date -65.4%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$484M	65.0%	$24.25	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$87.86M	11.8%	$11.77	$13.72	-14.2%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$81.61M	11.0%	$28.44	$10.96	+159.6%	ORDINARY SHARES	N62509109
—	RAPT THERAPEUTICS INC	2,794,000	$72.06M	9.7%	$25.79	$25.79	—	COM	75382E109
AURA	AURA BIOSCIENCES INC	3,039,892	$18.79M	2.5%	$6.18	$17.87	-65.4%	COM	05153U107